A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control

Running, not enrolling · Phase 2

Conditions studied: Myopia, Progressive

In brief

The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.

Key facts

Study ID
NCT06579287
Run by
Sunhawk Vision Biotech, Inc.
People needed
140
Starts
2025-01-22
Expected to finish
2026-12-01
Last updated by the study team
2026-01-23

Who can join

Age: 3 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.